Brown, Powel H <br/><br/>
Combination chemoprevention of HER2/neu-induced breast cancer using a cyclooxygenase-2 inhibitor and a retinoid X receptor-selective retinoid.  [electronic resource] 

 -  Cancer prevention research (Philadelphia, Pa.)  Aug 2008 
 - 208-14 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1940-6215 
<br/><br/><label>Standard No.: </label>10.1158/1940-6207.CAPR-08-0021  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bexarotene<br/>Carcinoma--genetics<br/>Celecoxib<br/>Cell Transformation, Neoplastic--drug effects<br/>Chemoprevention--methods<br/>Cyclooxygenase 2 Inhibitors--administration & dosage<br/>Drug Evaluation, Preclinical<br/>Eicosanoids--metabolism<br/>Female<br/>Genes, erbB-2--physiology<br/>Mammary Neoplasms, Experimental--genetics<br/>Mammary Tumor Virus, Mouse--genetics<br/>Mice<br/>Mice, Transgenic<br/>Pyrazoles--administration & dosage<br/>Retinoid X Receptors--agonists<br/>Retinoids--administration & dosage<br/>Substrate Specificity--drug effects<br/>Sulfonamides--administration & dosage<br/>Tetrahydronaphthalenes--administration & dosage